Digital therapeutics are quickly rising in popularity, with the advancement of technology…
183 Immuno-Oncology Companies Raised $46 Billion
Attempts to harness the immune system to fight cancer date back to the late 1800s. It has been less than 40 years since the first of these immuno-oncology therapies demonstrated success and obtained approval. Since then, nearly 40 cancer immunotherapies have received FDA approval.
$18 Billion Invested in 135 Cell Therapy Companies
Cell therapy was born in the 1930s when Paul Niehans earned the…
64 Microbiome Biotechs Raise $1.6 Billion in Investments
In the last decade, a relatively uncharted field exploded in the life…
Life Science Companies Step Up the Fight Against Vision Loss by raising $13B+ from over 300 investors
The number of adults at risk for vision loss grew substantially from…
CipherBio PRO Users Explore Hot Markets and Deal Activity by City, State and Country
You dove into the CipherBio ecosystem, discovering companies and investors rooted in…
Record Breaking Numbers in Life Science IPOs
The number of biotechs entering the public markets is at an all-time…
SVB Clients Receive Preferred Discounts on CipherBio PRO With Access to $580B+ in Global Life Science VC Funding
SVB Financial Group built and funded CipherBio to help Founders and CEOs…
Life Science M&A Focused on Immunotherapy and Antibodies
The life science M&A trend is not slowing down. Nearly $30B has…
Download $520B+ of Funding Data to Excel to Build Investor and Company Lists From CipherBio PRO
We listened to our CipherBio PRO VC and CEO users and increased…